Triple Marker Test Essential Prenatal Screening, Noida

The Triple Marker Test is a prenatal blood screening performed during the second trimester of pregnancy, typically between the 15th and 20th weeks. It measures levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3) in the mother's blood. This test helps assess the risk of certain fetal abnormalities, including Down syndrome, trisomy 18, and neural tube defects. While not diagnostic, the results indicate whether further diagnostic procedures, such as amniocentesis, might be recommended. The Triple Marker Test provides valuable insights, allowing expectant parents and doctors to prepare and manage pregnancy more effectively.